Use of Radiopharmaceuticals for Diagnosis, Treatment, and Follow-Up of Differentiated Thyroid Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 4, 2007-07 ,pp. : 399-409

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of epidermal growth factor receptor mRNA in peripheral blood of cervical cancer patients

By Mitsuhashi A.   Tanaka N.   Suzuka K.   Matsui H.   Seki K.   Sekiya S.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 480-485

Elsevier

Access to resources Recommend Favorite

Studies on oestrogen receptor- and - mRNA in breast cancer

By Cullen R.   Maguire T.M.   McDermott E.W.   Hill A.D.K.   O'Higgins N.J.   Duffy M.J.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1118-1122

Elsevier

Access to resources Recommend Favorite

Ability of the rhTSH stimulation test to predict relapse in patients with differentiated thyroid carcinoma, after long-term follow-up

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1281-1286

Spandidos Publications

Access to resources Recommend Favorite

Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study

By        

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1749-1754

Spandidos Publications

Access to resources Recommend Favorite